Treasurer of the State of North Carolina’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Buy
7,926
+167
+2% +$48.1K 0.01% 830
2025
Q4
$2.35M Sell
7,759
-657
-8% -$205K 0.01% 825
2025
Q3
$2.36M Sell
8,416
-636
-7% -$173K 0.01% 855
2025
Q2
$2.18M Buy
9,052
+406
+5% +$96K 0.01% 883
2025
Q1
$2.11M Buy
8,646
+340
+4% +$102K 0.01% 849
2024
Q4
$2.73M Sell
8,306
-130
-2% -$44.1K 0.01% 796
2024
Q3
$2.82M Buy
8,436
+30
+0.4% +$9.53K 0.01% 791
2024
Q2
$2.3M Sell
8,406
-782
-9% -$227K 0.01% 838
2024
Q1
$3.18M Buy
9,188
+60
+0.7% +$19.7K 0.01% 730
2023
Q4
$2.95M Sell
9,128
-363
-4% -$114K 0.01% 740
2023
Q3
$3.4M Buy
9,491
+40
+0.4% +$15.4K 0.02% 656
2023
Q2
$3.58M Sell
9,451
-190
-2% -$77.3K 0.02% 641
2023
Q1
$4.62M Buy
9,641
+60
+0.6% +$28.1K 0.03% 542
2022
Q4
$4.03M Buy
9,581
+130
+1% +$52.5K 0.02% 572
2022
Q3
$3.94M Buy
9,451
+110
+1% +$54.8K 0.03% 560
2022
Q2
$4.62M Buy
9,341
+1,237
+15% +$644K 0.03% 528
2022
Q1
$4.56M Buy
8,104
+116
+1% +$69.9K 0.03% 542
2021
Q4
$6.04M Buy
7,988
+36
+0.5% +$26.9K 0.03% 477
2021
Q3
$5.93M Buy
7,952
+255
+3% +$191K 0.03% 464
2021
Q2
$4.96M Sell
7,697
-370
-5% -$225K 0.03% 516
2021
Q1
$4.61M Sell
8,067
-25
-0.3% -$14.8K 0.03% 524
2020
Q4
$4.72M Buy
8,092
+33
+0.4% +$18.8K 0.03% 496
2020
Q3
$4.15M Sell
8,059
-22
-0.3% -$11.1K 0.03% 477
2020
Q2
$3.65M Sell
8,081
-1,013
-11% -$447K 0.03% 486
2020
Q1
$3.19M Buy
9,094
+3,635
+67% +$1.34M 0.03% 485
2019
Q4
$2.02M Buy
5,459
+53
+1% +$18.7K 0.02% 583
2019
Q3
$1.8M Sell
5,406
-5,379
-50% -$1.75M 0.02% 602
2019
Q2
$3.37M Buy
10,785
+27
+0.3% +$8.09K 0.02% 605
2019
Q1
$3.29M Buy
10,758
+97
+0.9% +$26.2K 0.02% 594
2018
Q4
$2.48M Buy
10,661
+200
+2% +$53.7K 0.02% 640
2018
Q3
$3.27M Buy
10,461
+3,783
+57% +$1.17M 0.02% 610
2018
Q2
$1.93M Buy
6,678
+2,637
+65% +$728K 0.02% 602
2018
Q1
$1.01M Buy
+4,041
New +$1.03M 0.03% 577

Other funds holding BIO

Treasurer of the State of North Carolina's BIO Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Bio-Rad Laboratories Class A (BIO) stake by 2.2% in Q1 2026, buying an estimated $48.1K and bringing the position to 7,926 shares worth $2.21M. The position accounts for 0.01% of the portfolio, ranked #830.

Treasurer of the State of North Carolina first reported a position in BIO in Q1 2018 and has held it in 33 quarters since. The position peaked at $6.04M in Q4 2021. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Treasurer of the State of North Carolina held 7,926 shares of Bio-Rad Laboratories Class A worth $2.21M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 167 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $48.1K.
  • Bio-Rad Laboratories Class A made up 0.01% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #830 holding.
  • Treasurer of the State of North Carolina first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 33 quarters since.
  • Treasurer of the State of North Carolina's Bio-Rad Laboratories Class A position peaked at $6.04M in Q4 2021.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.